{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:19:59Z","timestamp":1791821999030,"version":"4.3.4"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004706","name":"Zhejiang Normal University","doi-asserted-by":"publisher","award":["KLMEACM202309"],"award-info":[{"award-number":["KLMEACM202309"]}],"id":[{"id":"10.13039\/501100004706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LZ24H310002"],"award-info":[{"award-number":["LZ24H310002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.lfs.2025.124082","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T15:42:26Z","timestamp":1762702946000},"page":"124082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["METTLING in the pathogenesis of metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1016","volume":"383","author":[{"given":"Ya-qian","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-hai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2025.124082_bb0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2025.124082_bb0010","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2025.124082_bb0015","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2025.124082_bb0020","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic Steatohepatitis: A Review","volume":"323","author":"Sheka","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.lfs.2025.124082_bb0025","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3748\/wjg.v16.i18.2223","article-title":"Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease","volume":"16","author":"Basaranoglu","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2025.124082_bb0030","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lfs.2025.124082_bb0035","article-title":"Uncovering the human methyltransferasome","volume":"10, M110.000976","author":"Petrossian","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.lfs.2025.124082_bb0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0968-0004(03)00090-2","article-title":"Many paths to methyltransfer: a chronicle of convergence","volume":"28","author":"Schubert","year":"2003","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.lfs.2025.124082_bb0045","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/jacs.8b10277","article-title":"Deciphering determinants in ribosomal methyltransferases that confer antimicrobial resistance","volume":"141","author":"Bhujbalrao","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.lfs.2025.124082_bb0050","doi-asserted-by":"crossref","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.lfs.2025.124082_bb0055","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00225.2023","article-title":"Emerging role of N(6)-methyladenosine in the homeostasis of glucose metabolism","volume":"326","author":"Sun","year":"2024","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2025.124082_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116323","article-title":"Novel insights into the N(6)-methyladenosine RNA modification and phytochemical intervention in lipid metabolism","volume":"457","author":"Li","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.lfs.2025.124082_bb0065","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.1038\/s41467-022-34808-2","article-title":"N6-methyladenosine modification governs liver glycogenesis by stabilizing the glycogen synthase 2 mRNA","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2025.124082_bb0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/j.2040-4603.2014.tb00548.x","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.lfs.2025.124082_bb0075","article-title":"METTL14-induced M(6)a methylation increases G6pc biosynthesis, hepatic glucose production and metabolic disorders in obesity","volume":"12, e2417355","author":"Zheng","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.lfs.2025.124082_bb0080","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/HEP.0000000000000716","article-title":"M 6 A-mediated gluconeogenic enzyme PCK1 upregulation protects against hepatic ischemia-reperfusion injury","volume":"81","author":"Yu","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2025.124082_bb0085","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2025.124082_bb0090","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.ymthe.2022.02.021","article-title":"Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"30","author":"Yang","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2025.124082_bb0095","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2019.08.018","article-title":"METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism","volume":"518","author":"Xie","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2025.124082_bb0100","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1097\/CM9.0000000000002533","article-title":"Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism","volume":"136","author":"Ding","year":"2023","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.lfs.2025.124082_bb0105","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s42255-022-00622-9","article-title":"N(6)-methyladenosine (m(6)a) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation","volume":"4","author":"Peng","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.lfs.2025.124082_bb0110","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-021-00373-7","article-title":"Liver regeneration and inflammation: from fundamental science to clinical applications","volume":"22","author":"Campana","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2025.124082_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.lfs.2025.124082_bb0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13045-019-0839-x","article-title":"M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma","volume":"13","author":"Zuo","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.lfs.2025.124082_bb0125","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1194\/jlr.M069807","article-title":"Cholesterol 7\u03b1-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis","volume":"57","author":"Liu","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2025.124082_bb0130","first-page":"5550","article-title":"Mettl3-mediated m(6)a modification plays a role in lipid metabolism disorders and progressive liver damage in mice by regulating lipid metabolism-related gene expression","volume":"15","author":"Dai","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.lfs.2025.124082_bb0135","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1038\/s41467-021-27539-3","article-title":"The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2025.124082_bb0140","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s41467-020-15488-2","article-title":"METTL3 is essential for postnatal development of brown adipose tissue and energy expenditure in mice","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2025.124082_bb0145","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1038\/s41598-021-84218-5","article-title":"Human METTL7B is an alkyl thiol methyltransferase that metabolizes hydrogen sulfide and captopril","volume":"11","author":"Maldonato","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2025.124082_bb0150","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41418-017-0013-3","article-title":"Carnitine palmitoyltransferase 1C regulates cancer cell senescence through mitochondria-associated metabolic reprograming","volume":"25","author":"Wang","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2025.124082_bb0155","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.1100747","article-title":"Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase","volume":"306","author":"Zimmermann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.lfs.2025.124082_bb0160","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s12010-021-03486-z","article-title":"Low molecular pectin inhibited the lipid accumulation by upregulation of METTL7B","volume":"193","author":"Yang","year":"2021","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.lfs.2025.124082_bb0165","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.celrep.2018.10.068","article-title":"Circadian clock regulation of hepatic lipid metabolism by modulation of m(6)a mRNA methylation","volume":"25","author":"Zhong","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2025.124082_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-200401000-00001","article-title":"Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants","volume":"14","author":"Nelson","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.lfs.2025.124082_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104764","article-title":"CYP4F2 is a human-specific determinant of circulating N-acyl amino acid levels","volume":"299","author":"Tanzo","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2025.124082_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113367","article-title":"The methyltransferase METTL3-mediated fatty acid metabolism revealed the mechanism of cinnamaldehyde on alleviating steatosis","volume":"153","author":"Xu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2025.124082_bb0185","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ymthe.2021.09.016","article-title":"METTL3-m(6)A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease","volume":"30","author":"Peng","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2025.124082_bb0190","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.celrep.2016.10.070","article-title":"Adipose Snail1 regulates lipolysis and lipid partitioning by suppressing adipose triacylglycerol lipase expression","volume":"17","author":"Sun","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2025.124082_bb0195","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.yfrne.2014.04.001","article-title":"Neural innervation of white adipose tissue and the control of lipolysis","volume":"35","author":"Bartness","year":"2014","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.lfs.2025.124082_bb0200","article-title":"Adipose METTL14-elicited N(6) -Methyladenosine promotes obesity, insulin resistance, and NAFLD through suppressing \u03b2 adrenergic signaling and lipolysis","volume":"10","author":"Kang","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.lfs.2025.124082_bb0205","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2025.124082_bb0210","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.lfs.2025.124082_bb0215","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","article-title":"Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits","volume":"77","author":"Peiseler","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2025.124082_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.767314","article-title":"Current and potential therapies targeting inflammation in NASH","volume":"12","author":"Albhaisi","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.lfs.2025.124082_bb0225","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1016\/j.molcel.2021.10.028","article-title":"HRD1-mediated METTL14 degradation regulates m(6)a mRNA modification to suppress ER proteotoxic liver disease","volume":"81","author":"Wei","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.lfs.2025.124082_bb0230","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jcmgh.2021.04.001","article-title":"Mettl14-mediated m(6)a modification facilitates liver regeneration by maintaining endoplasmic reticulum homeostasis","volume":"12","author":"Cao","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2025.124082_bb0235","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.3389\/fimmu.2020.01802","article-title":"Chemokines in non-alcoholic fatty liver disease: a systematic review and network Meta-analysis","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.124082_bb0240","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2010.222844","article-title":"Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C","volume":"60","author":"Miquilena-Colina","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2025.124082_bb0245","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","article-title":"Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury","volume":"61","author":"Baeck","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2025.124082_bb0250","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.3389\/fimmu.2019.02852","article-title":"Therapeutic targeting of hepatic macrophages for the treatment of liver diseases","volume":"10","author":"van der Heide","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.124082_bb0255","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2025.124082_bb0260","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41419-020-2323-5","article-title":"Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2025.124082_bb0265","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2025.124082_bb0270","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2025.124082_bb0275","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41420-021-00756-x","article-title":"The METTL3\/MALAT1\/PTBP1\/USP8\/TAK1 axis promotes pyroptosis and M1 polarization of macrophages and contributes to liver fibrosis","volume":"7","author":"Shu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2025.124082_bb0280","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s13577-022-00769-3","article-title":"METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma","volume":"35","author":"Hu","year":"2022","journal-title":"Hum. Cell"},{"key":"10.1016\/j.lfs.2025.124082_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.109924","article-title":"METTL3\/16-mediated m(6)a modification of ZNNT1 promotes hepatocellular carcinoma progression by activating ZNNT1\/osteopontin\/S100A9 positive feedback loop-mediated crosstalk between macrophages and tumour cells","volume":"261","author":"Wei","year":"2024","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.lfs.2025.124082_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109968","article-title":"M(6)a mRNA methylation-directed myeloid cell activation controls progression of NAFLD and obesity","volume":"37","author":"Qin","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2025.124082_bb0295","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.immuni.2014.05.010","article-title":"Macrophages, immunity, and metabolic disease","volume":"41","author":"McNelis","year":"2014","journal-title":"Immunity"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2025.124082_bb0300","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis -- from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2025.124082_bb0305","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jhep.2017.06.001","article-title":"Hepatic stellate cell activation and pro-fibrogenic signals","volume":"67","author":"Gandhi","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2025.124082_bb0310","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.lfs.2025.124082_bb0315","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1369\/0022155415627681","article-title":"TGF-\u03b2\/SMAD pathway and its regulation in hepatic fibrosis","volume":"64","author":"Xu","year":"2016","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.lfs.2025.124082_bb0320","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2025.124082_bb0325","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2025.124082_bb0330","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jcmgh.2021.05.007","article-title":"METTL3\/METTL14 transactivation and m(6)A-dependent TGF-\u03b21 translation in activated Kupffer cells","volume":"12","author":"Feng","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2025.124082_bb0335","doi-asserted-by":"crossref","first-page":"505","DOI":"10.17305\/bb.2023.9698","article-title":"Silencing METTL14 alleviates liver injury in non-alcoholic fatty liver disease by regulating mitochondrial homeostasis","volume":"24","author":"Wang","year":"2024","journal-title":"Biomol. Biomed."},{"key":"10.1016\/j.lfs.2025.124082_bb0340","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-024-01797-1","article-title":"METTL14 downregulation drives S100A4(+) monocyte-derived macrophages via MyD88\/NF-\u03baB pathway to promote MAFLD progression","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.lfs.2025.124082_bb0345","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1016\/j.ymthe.2022.07.020","article-title":"The m(6)a methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis","volume":"30","author":"Li","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2025.124082_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2023.121887","article-title":"METTL3-mediated m6A mRNA modification was involved in cadmium-induced liver injury","volume":"331","author":"Li","year":"2023","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.lfs.2025.124082_bb0355","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/15476286.2020.1734372","article-title":"Identification of NOVA family proteins as novel \u03b2-catenin RNA-binding proteins that promote epithelial-mesenchymal transition","volume":"17","author":"Tang","year":"2020","journal-title":"RNA Biol."},{"key":"10.1016\/j.lfs.2025.124082_bb0360","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.gene.2018.06.053","article-title":"Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis","volume":"674","author":"Wang","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.lfs.2025.124082_bb0365","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000199","article-title":"METTL14 reverses liver fibrosis by inhibiting NOVA2 through an m6A-YTHDF2-dependent mechanism","volume":"7","author":"Hou","year":"2023","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.lfs.2025.124082_bb0370","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2025.124082_bb0375","article-title":"Molecular mechanisms in MASLD\/MASH-related HCC","author":"Wang","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2025.124082_bb0380","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1261\/rna.2030705","article-title":"tRNA m7G methyltransferase Trm8p\/Trm82p: evidence linking activity to a growth phenotype and implicating Trm82p in maintaining levels of active Trm8p","volume":"11","author":"Alexandrov","year":"2005","journal-title":"Rna"},{"key":"10.1016\/j.lfs.2025.124082_bb0385","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.661","article-title":"METTL1 promotes hepatocarcinogenesis via m(7) G tRNA modification-dependent translation control","volume":"11","author":"Chen","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.lfs.2025.124082_bb0390","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00109-019-01830-9","article-title":"METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN","volume":"97","author":"Tian","year":"2019","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.lfs.2025.124082_bb0395","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1158\/0008-5472.CAN-22-0963","article-title":"METTL1-mediated m7G tRNA modification promotes Lenvatinib resistance in hepatocellular carcinoma","volume":"83","author":"Huang","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2025.124082_bb0400","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1093\/nar\/gkz619","article-title":"The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112","volume":"47","author":"van Tran","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2025.124082_bb0405","doi-asserted-by":"crossref","first-page":"10755","DOI":"10.1038\/s41598-023-37807-5","article-title":"METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment","volume":"13","author":"Wang","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2025.124082_bb0410","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/cac2.12403","article-title":"METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression","volume":"43","author":"Xia","year":"2023","journal-title":"Cancer Commun. (Lond)"},{"key":"10.1016\/j.lfs.2025.124082_bb0415","article-title":"The m6A methyltransferase METTL5 promotes neutrophil extracellular trap network release to regulate hepatocellular carcinoma progression","volume":"13","author":"Wang","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.lfs.2025.124082_bb0420","article-title":"Downregulation of METTL6 mitigates cell progression, migration, invasion and adhesion in hepatocellular carcinoma by inhibiting cell adhesion molecules","volume":"60","author":"Bolatkan","year":"2022","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2025.124082_bb0425","article-title":"METTL6 is a tRNA m(3)C methyltransferase that regulates pluripotency and tumor cell growth","volume":"6, eaaz4551","author":"Ignatova","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.lfs.2025.124082_bb0430","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41420-023-01723-4","article-title":"METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition","volume":"9","author":"Bi","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2025.124082_bb0435","doi-asserted-by":"crossref","first-page":"21638","DOI":"10.18632\/aging.103959","article-title":"Analysis of METTL3 and METTL14 in hepatocellular carcinoma","volume":"12","author":"Liu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.lfs.2025.124082_bb0440","doi-asserted-by":"crossref","first-page":"135","DOI":"10.14715\/cmb\/2020.66.6.24","article-title":"Serum miR-885-5p can be used as a marker for efficacy prediction and prognosis of advanced liver cancer","volume":"66","author":"Wang","year":"2020","journal-title":"Cell Mol. Biol. (Noisy-le-grand)"},{"key":"10.1016\/j.lfs.2025.124082_bb0445","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4149\/neo_2020_200106N17","article-title":"miR-155-5p increases the sensitivity of liver cancer cells to adriamycin by regulating ATG5-mediated autophagy","volume":"68","author":"Yu","year":"2021","journal-title":"Neoplasma"},{"key":"10.1016\/j.lfs.2025.124082_bb0450","doi-asserted-by":"crossref","first-page":"754","DOI":"10.21037\/atm-20-3749","article-title":"miR-328-3p overexpression attenuates the malignant proliferation and invasion of liver cancer via targeting endoplasmic reticulum Metallo protease 1 to inhibit AKT phosphorylation","volume":"8","author":"Lu","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.lfs.2025.124082_bb0455","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/hep.28885","article-title":"METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing","volume":"65","author":"Ma","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2025.124082_bb0460","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nrc3985","article-title":"The multifaceted functions of sirtuins in cancer","volume":"15","author":"Chalkiadaki","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2025.124082_bb0465","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1158\/0008-5472.CAN-20-4163","article-title":"USP48 is upregulated by Mettl14 to attenuate hepatocellular carcinoma via regulating SIRT6 stabilization","volume":"81","author":"Du","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2025.124082_bb0470","doi-asserted-by":"crossref","DOI":"10.3892\/or.2024.8718","article-title":"m6A methyltransferase METTL14-mediated RP1-228H13.5 promotes the occurrence of liver cancer by targeting hsa-miR-205\/ZIK1","volume":"51","author":"Xu","year":"2024","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2025.124082_bb0475","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.cell.2017.05.003","article-title":"The U6 snRNA m(6)a methyltransferase METTL16 regulates SAM Synthetase intron retention","volume":"169","author":"Pendleton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2025.124082_bb0480","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1681","article-title":"RNA methyltransferase METTL16: targets and function","volume":"13","author":"Satterwhite","year":"2022","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.lfs.2025.124082_bb0485","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s11658-022-00342-8","article-title":"METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m(6)A-dependent manner","volume":"27","author":"Dai","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.lfs.2025.124082_bb0490","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13045-024-01526-9","article-title":"METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation","volume":"17","author":"Xue","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.lfs.2025.124082_bb0495","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41556-021-00835-2","article-title":"METTL16 exerts an m(6)A-independent function to facilitate translation and tumorigenesis","volume":"24","author":"Su","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.lfs.2025.124082_bb0500","doi-asserted-by":"crossref","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.lfs.2025.124082_bb0505","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the universal protein knowledgebase in 2023","volume":"51","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2025.124082_bb0510","article-title":"Identification METTL18 as a potential prognosis biomarker and associated with immune infiltrates in hepatocellular carcinoma","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2025.124082_bb0515","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12964-023-01148-7","article-title":"METTL3 and STAT3 form a positive feedback loop to promote cell metastasis in hepatocellular carcinoma","volume":"21","author":"Liu","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.lfs.2025.124082_bb0520","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canlet.2017.11.031","article-title":"Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling","volume":"423","author":"Long","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2025.124082_bb0525","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/jcmm.16845","article-title":"METTL3-mediated maturation of miR-589-5p promotes the malignant development of liver cancer","volume":"26","author":"Liu","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2025.124082_bb0530","first-page":"13423","article-title":"METTL3 facilitates the progression of hepatocellular carcinoma by modulating the m6A level of USP7","volume":"13","author":"Li","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.lfs.2025.124082_bb0535","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23931","article-title":"METTL3-mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis","volume":"35","author":"Wang","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.lfs.2025.124082_bb0540","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10456-020-09744-8","article-title":"RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via hippo pathway","volume":"24","author":"Qiao","year":"2021","journal-title":"Angiogenesis"},{"key":"10.1016\/j.lfs.2025.124082_bb0545","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/cam4.2918","article-title":"METTL3 expression is associated with glycolysis metabolism and sensitivity to glycolytic stress in hepatocellular carcinoma","volume":"9","author":"Lin","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.lfs.2025.124082_bb0550","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1002\/jcp.30128","article-title":"HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1\u03b1","volume":"236","author":"Yang","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2025.124082_bb0555","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41392-020-00453-8","article-title":"HIF-1\u03b1-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.lfs.2025.124082_bb0560","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103181","article-title":"RNA m(6) a methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy","volume":"39","author":"Lin","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.lfs.2025.124082_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216122","article-title":"METTL3-m(6)A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma","volume":"559","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2025.124082_bb0570","doi-asserted-by":"crossref","first-page":"13173","DOI":"10.2147\/CMAR.S286275","article-title":"METTL14 inhibits hepatocellular carcinoma metastasis through regulating EGFR\/PI3K\/AKT signaling pathway in an m6A-dependent manner","volume":"12","author":"Shi","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.lfs.2025.124082_bb0575","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2018.11.006","article-title":"YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma","volume":"442","author":"Zhong","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2025.124082_bb0580","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/hep.29683","article-title":"RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2","volume":"67","author":"Chen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2025.124082_bb0585","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2025.124082_bb0590","article-title":"METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy","volume":"4","author":"Pan","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.lfs.2025.124082_bb0595","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12935-023-03096-1","article-title":"Therapeutic effect and transcriptome-methylome characteristics of METTL3 inhibition in liver hepatocellular carcinoma","volume":"23","author":"Liu","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.lfs.2025.124082_bb0600","article-title":"Patent landscape of small molecule inhibitors of METTL3 (2020-present)","volume":"1-16","author":"Wu","year":"2024","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.lfs.2025.124082_bb0605","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2025.124082_bb0610","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.chembiol.2023.12.009","article-title":"Discovery of a PROTAC degrader for METTL3-METTL14 complex","volume":"31","author":"Du","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.lfs.2025.124082_bb0615","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1101\/gr.271635.120","article-title":"Acute depletion of METTL3 implicates N (6)-methyladenosine in alternative intron\/exon inclusion in the nascent transcriptome","volume":"31","author":"Wei","year":"2021","journal-title":"Genome Res."},{"key":"10.1016\/j.lfs.2025.124082_bb0620","article-title":"A stapled peptide inhibitor targeting the binding Interface of N6-adenosine-methyltransferase subunits METTL3 and METTL14 for Cancer therapy","volume":"63","author":"Li","year":"2024","journal-title":"Angew. Chem. Int. Ed. Eng."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525007180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525007180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:37:30Z","timestamp":1766072250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525007180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":124,"alternative-id":["S0024320525007180"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.124082","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"METTLING in the pathogenesis of metabolic dysfunction-associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.124082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124082"}}